Welcome to the new Gustave Roussy website

A new website designed to offer you a simpler, clearer, and more intuitive experience. Patients, caregivers, healthcare professionals, and donors: find information, news, and services more easily.

List of research teams

Molecular Characterization of Breast and Gynecologic Cancers

Thematic(s)
Genetics / Genomics, Precision Medicine, Tumor Metabolism, Tumor microenvironment
Manager(s)
Fabrice André
Institutional connection

Gustave Roussy, Inserm, Paris-Saclay University

Summary

Prof. Fabrice André : Molecular characterization of Breast & Gynecologic cancers Team / Dr. Geraldine Gentric : Cancer Metabolism & Therapy Resistance Lab / Dr Clara Nahmias : Microtubules & Cancers Lab / Prof. Alexandra Leary: Novel therapies & predictive biomarkers in gynecologic cancers Lab

Objectives and Challenges

The “Molecular Characterization of Breast and Gynecologic Cancers” team ," led by Fabrice André, is dedicated to studying the molecular and intratumoral heterogeneity of breast and gynecological cancers in order to identify actionable biomarkers and the factors responsible for disease progression. The team investigates the genomic, epigenomic, and spatial determinants of tumor evolution and metastatic spread, focusing on the mechanisms underlying treatment resistance in advanced gynecologic cancers. 

Research Areas/Major Projects

The work of the group led by Fabrice André aims to refine patient stratification and enable the implementation of more effective, biomarker-guided therapeutic strategies for aggressive forms of the disease (metastatic breast cancer). 

Within the team, Geraldine Gentric leads the MetaboCare group, which studies the links between metabolic reprogramming and cancer cell plasticity in treatment resistance and disease recurrence. This research combines spatial metabolomics, functional profiling, and the use of patient-derived cellular models to understand the effects of anticancer treatments on the remodeling of tumor cells. One of the key objectives of this research is to identify metabolic vulnerabilities in residual tumor cells and to translate these analyses into therapeutic strategies for patients with treatment-resistant cancers. This research is part of the UNLOCK program at the IHU PRISM.

The group led by Alexandra Leary seeks to identify new therapies and predictive biomarkers in ovarian, uterine, and cervical cancers by targeting the response to DNA damage and the tumor microenvironment. This research combines translational science and clinical trials to evaluate new therapeutic strategies. 

The “Microtubules and Cancer” group, led by Clara Nahmias, studies microtubule-associated proteins as prognostic and predictive biomarkers for triple-negative breast cancer and high-grade serous ovarian cancer, based on molecular studies conducted on patient cohorts. Studies of microtubule interactions with cellular organelles aim to develop new targeted therapies for specific patient populations.

Team members

  • ANDRÉ Fabrice - Team Leader

    University Professors and Hospital Practitioners, Gustave Roussy, Paris-Saclay University

     

    Bruno ACHUTTI-DUSO

    Hospital Physician, Gustave Roussy

     

    AGUADO Aurore

    Ph.D. Student, Other

     

    Carine AMSEYAN

    Other status, including apprentice, Gustave Roussy

     

    Noémie Barillot

    Other status, including apprentice, Gustave Roussy

     

    BAUDIN Eric

    Hospital Physician, Gustave Roussy

     

    Félix Blanc-Durand

    Ph.D. student, Paris-Saclay University

     

    BOINET, Marie

    Design Engineer or equivalent, Gustave Roussy

     

    DAIDJ Ferroudja

    Other status, including apprentice, Gustave Roussy

     

    Julia DIXON-DOUGLAS

    Hospital Physician, Gustave Roussy

     

    FERNADEZ MARTINEZ Aranzazu

    Hospital Physician, Gustave Roussy

     

    FERREIRA DO COUTO, Karine

    Research Technician or Equivalent, Gustave Roussy

     

    GARBERIS Ingrid

    Other status, including apprentice, Gustave Roussy

     

    Catherine Genestie

    Hospital Physician, Gustave Roussy

     

    Géraldine GENTRIC

    Research Fellow and Equivalents, Inserm

     

    GRAU-BEJAR Juan Francisco

    Ph.D. Student, Paris-Saclay University

     

    Magalie Lacroix-Triki

    Hospital Physician, Gustave Roussy

     

    LEARY Alexandra

    University Professors and Hospital Practitioners, Gustave Roussy, Paris-Saclay University

     

    Audrey LE FORMAL

    Research Technician or Equivalent, Gustave Roussy

     

    Angèle LUBY

    Research Engineer or Equivalent, Gustave Roussy

     

    MAZET Paul

    Ph.D. Student, Paris-Saclay

     

    Matthew MCKEON

    Research Technician or equivalent, Gustave Roussy

     

    MORAGON TERENCIO Santiago

    Ph.D. student, Inserm

     

    MORELLI Alessandra

    Postdoctoral Fellow, Gustave Roussy

     

    MOSELE Maria Fernanda

    Ph.D. student, Paris-Saclay

     

    NAHMIAS Clara

    Research Director and Equivalents, CNRS

     

    NAIM Valéria

    Research Associate and Equivalents, Inserm

     

    NURY Thomas

    Postdoctoral Fellow, Gustave Roussy

     

    PELOSI Michele

    Research Engineer or equivalent, Gustave Roussy

     

    PIC Isabelle

    Research Technician or equivalent, Gustave Roussy

     

    Sylvie RODRIGUES-FERREIRA

    Design Engineer or equivalent, CNRS

     

    ROULEAU Etienne

    Hospital Physician, Gustave Roussy

     

    SIREROL, Marine

    Research Engineer or equivalent, Gustave Roussy

     

    Charbel Soueidy

    Hospital Physician, Gustave Roussy

     

    TRAN Thi Ngoc Diep

    Research Engineer or equivalent, Gustave Roussy

     

    VERRET Benjamin

    Ph.D. Candidate, Paris-Saclay

     

    WHITTUM Andrew

    Other status, including apprentice, Gustave Roussy

     

    Elisa YANIZ-GALENDE

    Postdoctoral researcher, Gustave Roussy

     

    YVENOU Johan

    Ph.D. student, Paris-Saclay

Contacts

Location: Gustave Roussy Institute